Molecular biology of prostate cancer /

Saved in:
Bibliographic Details
Online Access: Full text (MCPHS users only)
Other Authors: Wirth, M.
Format: Electronic eBook
Language:German
Published: Berlin ; New York : Walter de Gruyter, 1998
Subjects:
Local Note:ProQuest Ebook Central

MARC

LEADER 00000cam a2200000 i 4500
001 in00000295766
006 m o d
007 cr cnu---unuuu
008 131002s1998 gw a ob 001 0 ger d
005 20240703151433.4
019 |a 922947756  |a 1055385061  |a 1065943549  |a 1081195720 
020 |a 9783110807271  |q (electronic bk.) 
020 |a 3110807270  |q (electronic bk.) 
020 |z 3110161591 
020 |z 9783110161595 
029 1 |a DEBBG  |b BV044053704 
035 |a (OCoLC)859262995  |z (OCoLC)922947756  |z (OCoLC)1055385061  |z (OCoLC)1065943549  |z (OCoLC)1081195720 
035 |a (OCoLC)ocn859262995 
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d OCLCO  |d OCLCF  |d YDXCP  |d EBLCP  |d OCLCO  |d OCLCQ  |d OCLCO  |d ZCU  |d MERUC  |d OCLCQ  |d OCLCO  |d DEGRU  |d OCLCA  |d UIU  |d ICG  |d OCLCA  |d VT2  |d OCLCQ  |d WYU  |d OCLCA  |d DKC  |d OCLCQ  |d UKAHL  |d UX1  |d OCLCQ  |d BRF  |d INARC  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ 
050 4 |a RC280.P7  |b M65 1998eb 
060 4 |a 1998 I-042 
060 4 |a WJ 752  |b M718 1998 
066 |c (S 
072 7 |a RC  |2 lcco 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.99/463  |2 23 
084 |a XH 8017  |2 rvk 
245 0 0 |a Molecular biology of prostate cancer /  |c editors, M. Wirth [and others]. 
264 1 |a Berlin ;  |a New York :  |b Walter de Gruyter,  |c 1998. 
300 |a 1 online resource (x, 208 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
505 0 0 |t Frontmatter --  |t Preface --  |t Contents --  |t List of first-mentioned contributors --  |t Cytogenetic alterations in prostate cancer /  |r Sauter, G. --  |t The regulation of prostatic growth /  |r Griffiths, K. --  |t Current concepts of oncogenes in prostate cancer /  |r Peehl, D. M. --  |t Tumour suppressor genes in prostate cancer /  |r Brewster, S. F. --  |t The use of differential display PCR for the detection of new tumor suppressor genes in prostate cancer /  |r Pilarsky, Ch. P. --  |t Molecular alterations associated with prostate cancer development /  |r Bussemakers, M. J. G. / Schalken, J. A. --  |t Dysfunction of the cell-cell adhesion complex in lethal prostate cancer /  |r Paul, R. / Isaacs, W. B. / Bova, G. S. --  |t Heparan sulfate proteoglycans and prostate cancer: a conceptual framework /  |r Schamhart, D. H. J. / Kurth, K.-H. --  |t Androgen receptor mutations in prostate cancer /  |r Klocker, H. / Culig, Z. / Hobisch, A. / Hittmair, A. / Bartsch, G. / Peterziel, H. / Cato, A. C. B. --  |t Antiandrogen binding to androgen receptors and the consequences /  |r Furr, B. J. A. --  |t Expression of the MDR1 gene in prostate carcinoma /  |r Siegsmund, M. J. / Schummer, B. / Steidler, A. / Greschner, M. / Köhrmann, K.-U. / Alken, P. --  |t Human prostate cancer progression models and therapeutic intervention /  |r Chung, L. W. K. / Kao, C. / Sikes, R. A. / Zhau, H. E. --  |t Tumor angiogenesis: the VEGF signalling system is a novel target for prostate cancer therapy /  |r Marmé, D. --  |t Antimetastatic approaches to therapy of prostate cancer /  |r Heicappell, R. --  |t Intermittent androgen suppression: rationale and clinical experience /  |r Gleave, M. / Bruchovsky, N. / Goldenberg, S. L. / Rennie, P. --  |t Resistance to drug therapy in cancer: gene therapy approaches to overcome anticancer drug resistance /  |r Licht, Th. --  |t PSA RT-PCR: current status and future potential /  |r Ellis, W. J. / Vessella, R. L. / Melchior, S. W. / Lange, P. H. --  |t Special aspects of PSMA and PSA RT-PCR for the detection of disseminated prostate cells /  |r Schmidt, B. / Bendhack, M. / Ackermann, R. / Schmitz-Dräger, B. J. --  |t Molecular forms of PSA, PSA density, age-/racespecific reference ranges, and PSA velocity /  |r Beduschi, M. C. / Beduschi, R. / Oesterling, J. E. --  |t Reverse transcriptase-polymerase chain reaction assays used for molecular staging of prostate cancer patients /  |r Olsson, C. A. / Buttyan, R. --  |t Concluding remarks /  |r Altwein, J. E. 
588 0 |a Print version record. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Prostate  |x Cancer  |x Molecular aspects. 
650 0 |a Prostate  |x Cancer  |x Treatment. 
650 1 2 |a Prostatic Neoplasms  |x genetics 
650 2 2 |a Prostatic Neoplasms  |x therapy 
700 1 |a Wirth, M. 
776 0 8 |i Print version:  |t Molecular biology of prostate cancer  |z 9783110161595  |w (OCoLC)39931134 
852 |b E-Collections  |h ProQuest 
856 4 0 |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=3044476  |z Full text (MCPHS users only)  |t 0 
880 0 0 |6 505-00/(S  |t Frontmatter --  |t Preface --  |t Contents --  |t List of first-mentioned contributors --  |t Cytogenetic alterations in prostate cancer /  |r Sauter, G. --  |t The regulation of prostatic growth /  |r Griffiths, K. --  |t Current concepts of oncogenes in prostate cancer /  |r Peehl, D.M. --  |t Tumour suppressor genes in prostate cancer /  |r Brewster, S.F. --  |t The use of differential display PCR for the detection of new tumor suppressor genes in prostate cancer /  |r Pilarsky, Ch. P. --  |t Molecular alterations associated with prostate cancer development /  |r Bussemakers, M.J.G. ; Schalken, J.A. --  |t Dysfunction of the cell-cell adhesion complex in lethal prostate cancer /  |r Paul, R. ; Isaacs, W.B. ; Bova, G.S. --  |t Heparan sulfate proteoglycans and prostate cancer: a conceptual framework /  |r Schamhart, D.H.J. ; Kurth, K.-H. --  |t Androgen receptor mutations in prostate cancer /  |r Klocker, H. ; Culig, Z. ; Hobisch, A. ; Hittmair, A. ; Bartsch, G. ; Peterziel, H. ; Cato, A.C. Β. --  |t Antiandrogen binding to androgen receptors and the consequences /  |r Furr, B.J.A. --  |t Expression of the MDR1 gene in prostate carcinoma /  |r Siegsmund, M.J. ; Schummer, Β. ; Steidler, A. ; Greschner, M. ; Köhrmann, K.-U. ; Alken, P. --  |t Human prostate cancer progression models and therapeutic intervention /  |r Chung, L.W.K. ; Kao, C. ; Sikes, R.A. ; Zhau, H.E. --  |t Tumor angiogenesis: the VEGF signalling system is a novel target for prostate cancer therapy /  |r Marmé, D. --  |t Antimetastatic approaches to therapy of prostate cancer /  |r Heicappell, R. --  |t Intermittent androgen suppression: rationale and clinical experience /  |r Gleave, M. ; Bruchovsky, N. ; Goldenberg, S.L. ; Rennie, P. --  |t Resistance to drug therapy in cancer: gene therapy approaches to overcome anticancer drug resistance /  |r Licht, Th. --  |t PSA RT-PCR: current status and future potential /  |r Ellis, W.J. ; Vessella, R.L. ; Melchior, S.W. ; Lange, P.H. --  |t Special aspects of PSMA and PSA RT-PCR for the detection of disseminated prostate cells /  |r Schmidt, B. ; Bendhack, M. ; Ackermann, R. ; Schmitz-Dräger, Β. J. --  |t Molecular forms of PSA, PSA density, age-/racespecific reference ranges, and PSA velocity /  |r Beduschi, M.C. ; Beduschi, R. ; Oesterling, J.E. --  |t Reverse transcriptase-polymerase chain reaction assays used for molecular staging of prostate cancer patients /  |r Olsson, C.A. ; Buttyan, R. --  |t Concluding remarks /  |r Altwein, J.E. 
938 |a YBP Library Services  |b YANK  |n 10819188 
938 |a EBSCOhost  |b EBSC  |n 627726 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3044476 
938 |a De Gruyter  |b DEGR  |n 9783110807271 
938 |a Askews and Holts Library Services  |b ASKH  |n AH25316452 
938 |a Internet Archive  |b INAR  |n molecularbiology0000unse_z2y0 
947 |a FLO  |x pq-ebc-base 
999 f f |s f7a7c3cd-0869-4eb7-94cb-d8925c8c67f2  |i d05c4a17-3545-47dc-a61b-a990cd760e8d  |t 0 
952 f f |a Massachusetts College of Pharmacy and Health Sciences  |b Online  |c Online  |d E-Collections  |t 0  |e ProQuest  |h Other scheme 
856 4 0 |t 0  |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=3044476  |y Full text (MCPHS users only)